Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers.

Literature DB >> 29380099

Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers.

Fay Kastrinos¹, Hajime Uno², Sapna Syngal^2,3.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2018 PMID： 29380099 DOI： 10.1007/s10689-018-0074-6

Source DB: PubMed Journal: Fam Cancer ISSN： 1389-9600 Impact factor: 2.375

× No keyword cloud information.

2 in total

1. Development and Validation of the PREMM₅ Model for Comprehensive Risk Assessment of Lynch Syndrome.

Authors: Fay Kastrinos; Hajime Uno; Chinedu Ukaegbu; Carmelita Alvero; Ashley McFarland; Matthew B Yurgelun; Matthew H Kulke; Deborah Schrag; Jeffrey A Meyerhardt; Charles S Fuchs; Robert J Mayer; Kimmie Ng; Ewout W Steyerberg; Sapna Syngal
Journal: J Clin Oncol Date: 2017-05-10 Impact factor: 44.544

2. Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.

Authors: A Goverde; M C W Spaander; D Nieboer; A M W van den Ouweland; W N M Dinjens; H J Dubbink; C J Tops; S W Ten Broeke; M J Bruno; R M W Hofstra; E W Steyerberg; A Wagner
Journal: Fam Cancer Date: 2018-07 Impact factor: 2.375

2 in total

1. Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews.

Authors: Kathleen F Mittendorf; Hannah S Lewis; Devan M Duenas; Donna J Eubanks; Marian J Gilmore; Katrina A B Goddard; Galen Joseph; Tia L Kauffman; Stephanie A Kraft; Nangel M Lindberg; Ana A Reyes; Elizabeth Shuster; Sapna Syngal; Chinedu Ukaegbu; Jamilyn M Zepp; Benjamin S Wilfond; Kathryn M Porter
Journal: Hered Cancer Clin Pract Date: 2022-06-10 Impact factor: 2.164

Review 2. Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.

Authors: Brandie Heald; Heather Hampel; James Church; Beth Dudley; Michael J Hall; Maureen E Mork; Aparajita Singh; Elena Stoffel; Jessica Stoll; Y Nancy You; Matthew B Yurgelun; Sonia S Kupfer
Journal: Fam Cancer Date: 2020-07 Impact factor: 2.375

2 in total

Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers.

1. Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.

2. Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.

1. Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews.

Review 2. Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.

1. Development and Validation of the PREMM₅ Model for Comprehensive Risk Assessment of Lynch Syndrome.